Parisa Khorasani Esmaili - Department of Pathology, Pathology and Stem Cells Research Center, Afzali Pour Medical Faculty, Kerman University of Medical Sciences, Kerman, Iran
Shahriar Dabiri - Department of Pathology, Pathology and Stem Cells Research Center, Afzali Pour Medical Faculty, Kerman University of Medical Sciences, Kerman, Iran
Sajjadeh Movahedinia - Department of Pathology, Pathology and Stem Cells Research Center, Afzali Pour Medical Faculty, Kerman University of Medical Sciences, Kerman, Iran
Saeedeh Shojaeepour - Department of Basic Sciences, Faculty of Veterinary Medicine, Shahid Bahonar University of Kerman, Kerman, Iran
Fatemeh Bagheri - Legal Medicine Research Center, Legal Medicine Organization, Kerman, Iran
Hanie Ranjbar - Department of Pathology, Pathology and Stem Cells Research Center, Afzali Pour Medical Faculty, Kerman University of Medical Sciences, Kerman, Iran
Manzumeh Shamsi Meymandi - Pathology and Stem Cells Research Center, Kerman Medical School, Kerman University of Medical Sciences, Kerman, Iran.
Elham Mohebi - Research Center for Modeling in Health, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran
Mehrdad Farokhniya - Infectious and Internal Medicine Department, Afzalipour Hospital, Kerman University of Medical Science, Kerman, Iran

Background & Objective: Since December ۲۰۱۹ in Wuhan, China there is a new form of pneumonia and after expansion in other countries, World Health Organization (WHO) called it Coronavirus Disease ۲۰۱۹ (COVID-۱۹). Since the clinical laboratory findings have played an important role in the progression of the disease, this study aimed to evaluate the laboratory findings in COVID-۱۹ patients (before vaccination).Methods: In this case-control study that was conducted from February to August ۲۰۲۰; the laboratory test status in ۱۰۱ positive COVID-۱۹ patients was evaluated and compared with ۱۰۱ healthy individuals.Results: The results of our study showed that ۲۱% of patients had low WBC, ۲۴.۷۵% low RBC, ۳۷.۶۲%, low Hb, ۱۸.۸۱% with low HCT, ۲۹.۷%, low Plt, ۴۱.۵۸% had High PT, ۷۱.۲۹% high CRP, ۱۷.۸۲% high urea, ۱۱.۸۸% high CR, ۱۵.۸۴% high LDH, ۱۰.۸۹% low sodium, ۱۴.۷۵% low potassium (K). The quantitative examination of blood factors showed that lymph%, mixed%, PLT, HCT, Hb, and RBC were higher in the control group than in the case group. While Neu%, WBC, PTT, CRP, UREA, LDH, K in the patient group were higher than in the control group.Conclusion: According to the results of the study, it can be concluded that in the clinical treatment of COVID-۱۹ patients, much attention should be paid to the laboratory indicators to identify and intervene early in critically ill patients.

COVID-۱۹, laboratory test, Coronavirus